Celebrating Four New St. Baldrick’s Foundation Research Grants

by St. Baldrick's Foundation
January 12, 2023

Announcing $400,000 in new research grants next to science laboratory equipment

January is usually a time to relax after holiday celebrations – but we aren’t done celebrating yet. Because of the support of St. Baldrick’s Hero Funds and donors like you, we can celebrate four new research grants this month.

These grants were made in response to a specific Request For Applications in disease areas in which St. Baldrick’s typically sees a low number of applications.

Dr. Mitchell Cairo will work to develop immunotherapeutic agents to enhance the functions of Natural Killer cells to kill Burkitt lymphoma. Natural Killer cells are type of immune cell that can kill cancer cells. If successful this would offer a potentially more effective and less toxic treatment option, ultimately leading to improved survival. This grant is supported by the Jack’s Pack – We Still Have His Back Hero Fund.

Dr. Saba Ghassemi is working to develop CAR T cells faster and with increased strength to fight pediatric glioblastoma (GBM). She will combine these CAR T cells with a metabolic strategy to overcome the metabolic nature of tumor environment. This will lead to superior immunotherapy treatments against pediatric GBM. This grant is supported by the Be Brooks Brave Fund Hero Fund.

Ewing sarcoma, an aggressive bone cancer that occurs in children and young adults, is caused by an abnormal protein (EWS-FLI1) that stops cells from maturing into normal tissues. Dr. Joseph Ludwig is using powerful gene editing tools to systematically turn the EWS-FLI1 protein up or down and then measure whether such changes allow cancer cells to behave more normally. The information gained from this research is expected to lead to new anti-cancer treatments for adolescents and young adults battling Ewing sarcoma. This grant is supported by the Shohet Family Fund for Ewing Sarcoma Research Hero Fund.

Dr. Kimberly Stegmaier and colleagues have used a technology called CRISPR to identify new therapeutic targets for Ewing sarcoma. They prioritized a class of targets which are expressed in immature but not mature tissues. These proteins are often abnormally re-expressed in cancers such as Ewing sarcoma. Thus, drugs targeting these proteins would be expected to have minimal toxicity. Dr. Stegmaier will validate these therapeutic targets in Ewing sarcoma. This project has exciting translational potential for patients with Ewing sarcoma. This grant is supported by the The Ben Brandenburg Fund for Ewing Sarcoma Research Hero Fund.

As we look ahead into 2023 and beyond, this research gives kids with cancer hope. Keep a look out for our next grants announcement later this Spring. To learn more about the Hero Fund program check out this blog.

Donate now and help support research into better treatments for kids with cancer.


Read more on the St. Baldrick’s blog:


2022 Infrastructure Grants to Support Clinical Trials

by St. Baldrick's Foundation
November 21, 2022


Research Outcomes: Building Hope

by St. Baldrick's Foundation
November 15, 2022

This research is powered by you. This quarterly edition of the St. Baldrick’s Foundation Research Outcomes recognizes promising research to improve survival rates, provide holistic therapies, and translate adult drugs into pediatric trials.

Thank you for making research possible.

Lab equipment with text Research Outcomes

Read more »


Using Precision Medicine to Improve Pediatric Cancer Treatment

by St. Baldrick's Foundation
November 1, 2022

EXCITING UPDATE November 1, 2022: The largest academic collaboration of its kind was announced last month, and it builds off this St. Baldrick’s supported work. The Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute and St. Jude Children’s Research Hospital will collaborate to transform and accelerate the identification of vulnerabilities in pediatric cancers and translate them into better treatments.

Dr. Stegmaier said, “The Pediatric Cancer Dependency Map provided our community with a treasure trove of new data. However, the next critical step was to validate candidate gene targets emerging from this project. The St. Baldrick’s Foundation Robert J Arceci Innovation Award provided the critical funding for us to demonstrate the power of the Pediatric Cancer Dependency Map. 

With St. Baldrick’s support, we validated new candidate therapeutic targets in childhood cancers, such as Ewing sarcoma and neuroblastoma, which have led to the launching of drug discovery efforts, and we have gained novel insights into the mechanistic underpinnings of these diseases.  We were able to show our community the power of the project. I think we are just at the tip of the iceberg.  We are all very excited about the promise of what is to come through this new large-scale collaboration.”

We are excited to see the impact this collaboration has in helping to conquer childhood cancer.

Read more »


Update: More Hope for Children with Cancer in Africa

by Becky C. Weaver, Chief Mission Officer, St. Baldrick's Foundation
October 27, 2022

Of the many incredible things St. Baldrick’s donors have made possible for kids with cancer, one stands out to me like no other. The return on investment from this one grant has already far exceeded expectations, and each year its impact continues to grow. 

A Seed Planted

With the goal of training doctors from low- and middle-income countries, the first St. Baldrick’s International Scholar was awarded in 2013. But while Dr. Joseph Lubega of Uganda was in training at Baylor College of Medicine in Houston, he was also planting a seed: He set up the first pediatric oncology program for pediatricians in his home country. 

With St. Baldrick’s support, Dr. Lubega became one of the first trained pediatric oncologists in all of Uganda, where the need is great – as it is across Africa.

Map infographic of Childhood Cancers in U.S. & Africa

Read more »


Research Outcomes: Your Dollars at Work

by St. Baldrick's Foundation
August 8, 2022

Read on to learn about some of the research that – thanks to you – is changing the world of childhood cancer care.

lab equipment with text Research Outcomes

Read more »


Announcing St. Baldrick’s Foundation July 2022 Grants 

by St. Baldrick's Foundation
July 27, 2022


Q&A On Fertility After Adolescent or Young Adult Cancer

by St. Baldrick's Foundation
June 9, 2022

Each survivor’s risk of late effects of cancer treatment depends on their tumor, specific treatments, age, genetic makeup and other factors. Surgeries, chemotherapies, radiation, stem cell transplants and other treatments take a toll on the body – and sometimes the mind – in many ways. Some late effects make life more difficult; others are life-threatening.

Heart and lung problems are common, as are secondary cancers.

Other late effects can include hearing problems, hormonal imbalances, difficulty growing, mental health needs or cognitive deficiencies, bone density issues and easy bone fractures, fertility and reproductive problems, and more.

Survivorship is a lifelong journey. By age 50 childhood cancer survivors have experienced, on average, 17 adverse effects, 3 to 5 of those being severe to life-threatening. Also by age 50, over 99% of today’s childhood cancer survivors have a chronic health problem by age 50 because of the treatments they had as kids.

Read more »


Research Outcomes: Incredible Impact and Hope

by St. Baldrick's Foundation
May 13, 2022

Formerly known as the St. Baldrick’s – Stand Up to Cancer Pediatric Cancer Dream Team, this team is now the St. Baldrick’s EPICC Team (Empowering Pediatric Immunotherapies for Childhood Cancer).

Your generosity makes a difference for children and young adults with cancer. Read on to see a few recent examples of the incredible impact you have on pediatric cancer research.

image of lab equipment with text Research Outcomes

Read more »


Rolling Up Their Lab Coat Sleeves: The 2022 St. Baldrick’s Fellows

by St. Baldrick's Foundation
March 14, 2022

The next generation of childhood cancer researchers is rolling up their lab coat sleeves and doubling down on the fight to end childhood cancers.

Thanks to donors like you, these doctors will train with leaders in the field and launch new research projects to answer pressing questions in the quest to conquer childhood cancers.

Explore the new research you’re supporting:

New fellow headshots with text Announcing New St. Baldrick’s Foundation Fellowships

Read more »

 Older Posts »